Mission Scientific Advisory Board Intellectual Property
back

Intellectual Property Actions

VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
VisEn Inter Partes Re-Examination Action filed Against Caliper Life Sciences Patent US 7,255,851
USPTO Order Granting VisEn Inter Partes Re-Examination: Substantial New Question of Patentability for All US 7,255,851 Claims
USPTO Inter Partes Re-Examination Office Action Rejecting All Seventeen Claims of the Caliper Life Sciences Patent US 7,255,851

USPTO Inter Partes Re-Examination Action Closing Prosecution (ACP) Rejecting All Eighteen Claims of the Caliper Life Sciences Patent US 7,255,851